SCHEMBL2767906

SCHEMBL2767906

CN(C)c1ccc(NC(=O)N(S)c2noc3ccc(Br)cc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.47
NPC1 O15118 3/20 0.41
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
GFER P55789 1/20 0.40
MAPT P10636 5/20 0.39
LMNA P02545 2/20 0.39
TDP1 Q9NUW8 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HTT P42858 1/20 0.37
MAPK1 P28482 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 1/20 0.36
RECQL P46063 1/20 0.36
MCL1 Q07820 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
EGFR P00533 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2768329 0.84 HIF1A (0.63) HIF1ANPC1GFERMAPTLMNA
SCHEMBL2768777 0.79 KMT2A (0.42) NPC1MAPTLMNATDP1MEN1
SCHEMBL2768044 0.76 RAB9A (0.41) NPC1MAPTLMNATDP1MEN1
SCHEMBL2767903 0.74 NPC1 (0.46) HIF1ANPC1NCOA1NCOA3GFER
SCHEMBL2770643 0.74 MAPT (0.44) NPC1GFERMAPTMEN1KMT2A
SCHEMBL2768458 0.73 HCRTR1 (0.50) HIF1ANPC1MAPTLMNAMEN1
SCHEMBL2784413 0.73 EPHX2 (0.44) NPC1MAPTLMNAHTTRAB9A
SCHEMBL2769321 0.71 HIF1A (0.56) HIF1ANPC1LMNAALDH1A1RAB9A
SCHEMBL2771191 0.70 SMN1; SMN2 (0.50) HIF1ANPC1MAPTLMNAMEN1
SCHEMBL2784887 0.69 HIF1A (0.39) HIF1ANPC1NCOA1NCOA3GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881967-B1 SUBSTITUTED BENZO(D)ISOXAZOL-3-YL AMINE COMPOUNDS AS ANALGESICS GRUENENTHAL GMBH (DE) 2010-04-28 EP claimed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US claimed
US-7696238-B2 Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics GRUENENTHAL GMBH (DE) 2010-04-13 US disclosed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics KCNQ1, KCNQ2, KCNQ3 HIF1A 1664/4885NPC1 2230/4885NCOA1 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.